Tracers / [18F]ADPM06

[18F]ADPM06

Also written as [18F]ADPM06; [F-18]ADPM06
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
—
Stage
—
Syntheses indexed
1
Preclinical only, no clinical indication yet

What it is

Compound class
BF2-chelated tetraaryl-azadipyrromethene photosensitizer
Target / mechanism
—
Clinical application
—
Theranostic pair
—

Regulatory status

FDA
—
EMA (centralised)
—
Other approvals
—
Brand names
—

Clinical use

Typical injected activity
—
Uptake time
—

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
COSMiC-Compact
NMP Business Support
—HPLC13 ± 2.7%
yes
> 95%ADPM06
BOC Sciences
37458904
2023 EJNMMI Radiopharm Chem
[18F]ADPM06 was synthesized using a COSMiC-Compact Synthesizer (NMP Business Support Company, Sanda, Japan). — The decay-corrected radiochemical yield from [18F]F− at the start of synthesis was 13 ± 2.7% (n = 5).

Need this precursor?We can point you to suppliers for [18F]ADPM06, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
—
USP monograph
—
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]ADPM06.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18.